Accent Therapeutics
Accent Therapeutics is a RNA-modifying protein inhibitors founded in 2017 by Robert Copeland.
2
Funding Rounds
$103.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ro**** Co****** |
|
- |
Funding
Funding series
Funding Series Analysis
The company Accent Therapeutics has raised a total of $103m in funding over 2 rounds.
Key Insights:
- Accent Therapeutics Series B round, April 2020: $63m
- Accent Therapeutics funding round, May 2018: $40m
Accent Therapeutics Series B round, April 2020
$63m
Accent Therapeutics funding round, May 2018
$40m
Industries
Accent Therapeutics is active in the following industries: